Viral Vector Upstream Processing Course
Learn at Your Own Pace from Top Experts in the Industry
This course provides an overview of the essential elements necessary to be successful in the upstream processing of viral vectors (primarily AAV, LV and ADV): analytical tools, process development considerations and manufacturing strategies. It will also offer insight into the market and trends, as well as industry needs and challenges.
- Mix of self-paced and instructional units (4–5 hours per week, 35–40 hours total over 2.5 months)
- Interactive collaborative platform
- Limited synchronous activities
- 98% recommendation rate
Who Should Attend
Lab managers, team leads, researchers, engineers and scientists with expertise in bioprocessing and basic knowledge of gene therapy. Fluent English is essential for optimal learning.
What You Will Learn
Upon completion of this course, you will:
- Understand various viral vectors and cell line requirements
- Explain upstream process development considerations and tools
- Discuss process control and manufacturing strategies
How You Will Learn
This online course consists of self-led and instructional units presented via MS Teams. Each chapter includes live presentations, assignments, access to experts and Q&A sessions to encourage collaboration.
Structured for Your Success
Each of our courses is structured to maximize the success of our learners, with a mix of self-paced and instructional units taught by industry experts. Courses are organized into logical chapters that cover a complete topic in approximately 2.5 months.
Sept 20 - 21
Sept 22 - Oct 1
Introduction to Viral Vectors
Oct 4 - 15
Cell Lines, Viral Vectors and Banking
Oct 25 - Nov 10
Nov 22 - Dec 3
Process Development and Manufacturing
Dec 9 - 10
Duration: 1.5 weeks
- Viral vector market, trends and opportunities
- Description of the adeno-associated virus (AAV), lentivirus (LV) and adenovirus (ADV)
- The basics of the viral vector manufacturing process
Duration: 2 weeks
- Review of typical cell line used for viral vector production
- Transient production (transfection, infection) and stable production
- Introduction to cell banking, virus banking, required testing and regulatory considerations
Duration: 2.5 weeks
- Where and why analytics are used in viral vector processes
- Introduction to the commonly used analytical solutions
- Considerations and challenges when selecting analytical methods
Duration: 2 weeks
- AAV, LV and ADV upstream workflows
- Key process development considerations: cell culture optimization, adherent vs. suspension production, process optimization and scale-up
- Production strategies for viral vectors
- Process controls and analytics during production
Pricing and Special Rates
Registration fee: €2,500 + applicable taxes.
Special rates may be considered for public and academic institutes. Contact firstname.lastname@example.org for further information.
For terms and conditions, click here
The application period closes 31 August 2021. Successful applicants will be informed by 10 September 2021. 20 seats are reserved for participants from the biopharmaceutical industry.
How to Apply
Please complete the application below. A maximum of 30 participants (co-learners from both Sartorius and industry) will be accepted to the course. Questions about the application should be directed to email@example.com.